Mylan launches generic schizophrenia, bipolar disorder drug

PITTSBURGH — Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.



Mylan announced the launch of olanzapine tablets in the 2.5-mg, 5-mg, 7.5-mg, 10-mg, 15-mg and 20-mg strengths.



The drug, a generic version of Eli Lilly's Zyprexa, is used to treat schizophrenia and bipolar disorder. Various versions of the drug had sales of about $3.3 billion in 2011, according to IMS Health.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.